Article Text

Download PDFPDF
Creating the position of surgical pharmacist in China
  1. Zhihua Zheng1,
  2. Junyan Wu2,
  3. Yingtong Zeng3,
  4. Ruolun Wang4,
  5. Jinghao Wang5,
  6. Yong Wang1
  1. 1 Guangdong Province Pharmaceutical Association, Guangzhou, China
  2. 2 Department of Pharmacy, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
  3. 3 Department of Pharmacy, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Guangzhou, China
  4. 4 Department of Pharmacy, Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
  5. 5 Department of Pharmacy, The First Affiliated Hospital, Jinan University, Guangzhou, China
  1. Correspondence to Dr Zhihua Zheng, Guangdong Province Pharmaceutical Association, Guangzhou 510080, China; snownotrace{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Chinese hospital pharmacists must face the challenge of the Zero-Markup Drug Policy which has been implemented since 2017 in China. The policy mandates all drugs to be sold in hospitals with no markup on price. Besides pharmacist-managed clinics (PMCs),1 we found the surgery department may be a good place for pharmacists to play a role, because most surgeons are more interested in surgical procedures than medicinal treatment, and irrational drug usage is more common in the surgery department than in the internal medicine department.

At the end of 2015, Guangdong Province Pharmaceutical Association (GDPA) put forward the concept of ‘surgical pharmacist’ first in China. The implementation of the Zero-Markup Drug Policy forced GDPA to create the position …

View Full Text


  • Contributors ZZ planned and wrote the manuscript. JW, YZ, and RW collected the data. JW, YZ, RW, JW, and YW reviewed the manuscript for critical content. All authors read and approved the final manuscript.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; internally peer reviewed.